W. Dieter Paar - Concepedia

Author

W. Dieter Paar

Also Known As

Berndt Lüderitz, Karl-Ludwig von Hanstein, Peter Bramlage, W D Paar, W Dieter Paar, W Paar, W. D. Paar, W. Dieter Paar, W.D. Paar, W.Dieter Paar

Publications

742

Citations

H-Index

Concepts

All Affiliations

Sanofi (Germany)University Hospital Carl Gustav Carus Mahlo (Germany)Charité - Universitätsmedizin Berlin St. Josefs-Hospital Cloppenburg

About

W. Dieter Paar is an author at Sanofi (Germany) specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	157
2	Public Health	3	3	137
3	Diabetes	1	1	91
4	Epidemiology	1	1	31
5	Global Health	1	1	91

W. Dieter Paar

Publications

456

Citations

H-Index

Page 1

	Year	Citations
Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: A sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients Ulrich Kintscher, Peter Bramlage, W. Dieter Paar, Cardiovascular Diabetology	2007	98
Ramipril-based versus diuretic-based antihypertensive primary treatment in patients with pre-diabetes (ADaPT) study Walter Zidek, Joachim Schrader, Stephan Lüders, Cardiovascular Diabetology	2012	94
A Global Perspective on Blood Pressure Treatment and Control in a Referred Cohort of Hypertensive Patients Peter Bramlage, Michael Böhm, Massimo Volpe, Journal of Clinical Hypertension HypertensionHeart FailurePreventive CardiologyBlood PressureNon-pharmacological Intervention	2010	91
Influence of the angiotensin converting enzyme inhibitor ramipril on high-sensitivity C-reactive protein (hs-CRP) in patients with documented atherosclerosis Veselin Mitrović, H. H. Klein, N. Krekel, Zeitschrift für Kardiologie InflammationThrombosisHypertensionVascular DiseaseEnzyme Inhibitor Ramipril	2005	31
PEARL: A Non-interventional Study of Real-World Alirocumab Use in German Clinical Practice Klaus G. Parhofer, Berndt von Stritzky, Nicole Pietschmann, Drugs - Real World Outcomes	2019	23
An Evaluation of Venous Thromboembolic Risk in Acutely Ill Medical Patients Immobilized at Home: The AT-HOME Study Sylvia Haas, V. Hach-Wunderle, Frank H. Mader, Clinical and Applied Thrombosis/Hemostasis	2007	22
Diagnosis of impaired glucose tolerance in hypertensive patients in daily clinical practice Stephan Lüders, F. Hammersen, Anke Kulschewski, International Journal of Clinical Practice	2005	20
Quality of anticoagulation with unfractionated heparin plus phenprocoumon for the prevention of thromboembolic complications in cardioversion for non-valvular atrial fibrillation. Sub-analysis from the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial Caroline Schmidt‐Lucke, W. Dieter Paar, Christoph Stellbrink, Thrombosis Research ThrombosisThromboembolic ComplicationsCardiovascular DiseaseNon-valvular Atrial FibrillationUnfractionated Heparin	2006	20
First-line antihypertensive treatment in patients with pre-diabetes: Rationale, design and baseline results of the ADaPT investigation Walter Zidek, Joachim Schrader, Stephan Lüders, Cardiovascular Diabetology	2008	16
Indication, outcome and follow up of intensive care in patients with HIV-infection. Ludger Leifeld, J Rockstroh, S Skaide, PubMed	2000	15

Page 1